Neoadjuvant Therapy for HER2-Positive Breast CancerNeoadjuvant Therapy for HER2-Positive Breast Cancer

Learn more about the most effective treatment modality in the neoadjuvant setting for HER2-positive breast cancer. Journal of the National Cancer Institute

Source: Medscape Today Headlines - December 30, 2014 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news